MS-based metabolomics revealing Bornean Sinularia sp. extract dysregulated lipids triggering programmed cell death in Hepatocellular carcinoma.
Yee Soon LingLeong Rui LimYoong Soon YongOriana TaminPerng Yang PuahPublished in: Natural product research (2018)
Soft coral, Sinularia sp. had been proven to inherit promising anti-cancer properties against variety of cancer. Current study, Sinularia sp. extract was introduced to Hepatocellular carcinoma (Hep 3B). Cell viability assay indicated the extract exhibit a dose and time dependent cytotoxicity. LC50 exhibited the lowest at 72 h post treatment estimated as 45.3 µg/mL. Morphological alterations including nuclear condensation, cytoplasm shrinkage and deformed cellular shape in treated Hep 3B were observable. Chemometric analysis revealed hydrophobic metabolites were significantly altered. Elevated vitamin D and derivatives tend to up-regulation Ca2+ and ROS subsequently triggering apoptosis. Dysregulated glycerolipids may suggest that they were biotransformed to compensate the needs of phospholipids during cell damage. Perturbation of sphingolipids, ceramide and carbohydrate-conjugated ceramides species increased the release of pro-apoptotic components reside within mitochondria and promote programmed cell death in treated Hep 3B. To conclude, MS-based metabolomics enabled the characterization of Sinularia sp. extract-induced cell death.
Keyphrases
- cell death
- oxidative stress
- mass spectrometry
- anti inflammatory
- cell cycle arrest
- ms ms
- diabetic rats
- multiple sclerosis
- single cell
- dna damage
- papillary thyroid
- high throughput
- cell therapy
- liquid chromatography
- endoplasmic reticulum stress
- photodynamic therapy
- reactive oxygen species
- ionic liquid
- newly diagnosed
- cell proliferation
- mesenchymal stem cells
- combination therapy
- lymph node metastasis
- stem cells
- gas chromatography
- tandem mass spectrometry